Glenview Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $418K | Hold |
7,582
| – | – | 0.01% | 385 |
|
|
2025
Q4 | $372K | Buy |
7,582
+369
| +5% | +$17.2K | 0.01% | 401 |
|
|
2025
Q3 | $311K | Sell |
7,213
-233
| -3% | -$9.1K | ﹤0.01% | 428 |
|
|
2025
Q2 | $286K | Buy |
7,446
+233
| +3% | +$8.9K | ﹤0.01% | 438 |
|
|
2025
Q1 | $279K | Sell |
7,213
-656
| -8% | -$24K | 0.01% | 419 |
|
|
2024
Q4 | $266K | Sell |
7,869
-1,068
| -12% | -$38.4K | 0.01% | 432 |
|
|
2024
Q3 | $365K | Buy |
8,937
+83
| +0.9% | +$3.4K | 0.01% | 390 |
|
|
2024
Q2 | $341K | Sell |
8,854
-300
| -3% | -$12.6K | 0.01% | 389 |
|
|
2024
Q1 | $392K | Sell |
9,154
-18
| -0.2% | -$742 | 0.01% | 376 |
|
|
2023
Q4 | $340K | Buy |
9,172
+18
| +0.2% | +$646 | 0.01% | 388 |
|
|
2023
Q3 | $332K | Buy |
9,154
+737
| +9% | +$26.2K | 0.01% | 367 |
|
|
2023
Q2 | $300K | Sell |
8,417
-460
| -5% | -$16.5K | 0.01% | 383 |
|
|
2023
Q1 | $316K | Hold |
8,877
| – | – | 0.01% | 370 |
|
|
2022
Q4 | $312K | Buy |
8,877
+960
| +12% | +$32K | 0.01% | 358 |
|
|
2022
Q3 | $233K | Sell |
7,917
-1
| -0% | -$38 | 0.01% | 378 |
|
|
2022
Q2 | $431K | Buy |
7,918
+88
| +1% | +$4.86K | 0.02% | 306 |
|
|
2022
Q1 | $426K | Hold |
7,830
| – | – | 0.01% | 322 |
|
|
2021
Q4 | $432K | Hold |
7,830
| – | – | 0.01% | 314 |
|
|
2021
Q3 | $374K | Sell |
7,830
-80
| -1% | -$4.02K | 0.01% | 312 |
|
|
2021
Q2 | $394K | Sell |
7,910
-4,640
| -37% | -$223K | 0.02% | 309 |
|
|
2021
Q1 | $560K | Buy |
12,550
+4,640
| +59% | +$211K | 0.02% | 244 |
|
|
2020
Q4 | $364K | Sell |
7,910
-58
| -0.7% | -$2.66K | 0.02% | 273 |
|
|
2020
Q3 | $375K | Sell |
7,968
-518
| -6% | -$26K | 0.02% | 256 |
|
|
2020
Q2 | $433K | Hold |
8,486
| – | – | 0.02% | 242 |
|
|
2020
Q1 | $402K | Buy |
8,486
+226
| +3% | +$12.1K | 0.03% | 230 |
|
|
2019
Q4 | $485K | Sell |
8,260
-196
| -2% | -$10.9K | 0.03% | 237 |
|
|
2019
Q3 | $451K | Buy |
8,456
+101
| +1% | +$5.2K | 0.03% | 245 |
|
|
2019
Q2 | $418K | Buy |
8,355
+95
| +1% | +$4.77K | 0.03% | 251 |
|
|
2019
Q1 | $432K | Sell |
8,260
-276
| -3% | -$13.8K | 0.03% | 244 |
|
|
2018
Q4 | $407K | Buy |
8,536
+292
| +4% | +$14.4K | 0.03% | 243 |
|
|
2018
Q3 | $414K | Buy |
8,244
+719
| +10% | +$36.5K | 0.03% | 253 |
|
|
2018
Q2 | $379K | Sell |
7,525
-13,036
| -63% | -$657K | 0.03% | 235 |
|
|
2018
Q1 | $1M | Buy |
20,561
+682
| +3% | +$31.8K | 0.07% | 179 |
|
|
2017
Q4 | $881K | Hold |
19,879
| – | – | 0.06% | 185 |
|
|
2017
Q3 | $1.01M | Sell |
19,879
-2,379
| -11% | -$121K | 0.07% | 166 |
|
|
2017
Q2 | $1.2M | Sell |
22,258
-199
| -0.9% | -$10.6K | 0.09% | 146 |
|
|
2017
Q1 | $1.18M | Hold |
22,457
| – | – | 0.09% | 145 |
|
|
2016
Q4 | $1.08M | Buy |
+22,457
| New | +$1.11M | 0.09% | 149 |
|
|
2015
Q4 | $504K | Buy |
+9,998
| New | +$510K | 0.05% | 177 |
|
|
2014
Q4 | $539K | Buy |
+10,089
| New | +$564K | 0.06% | 155 |
|
|
2013
Q4 | $836K | Buy |
+12,521
| New | +$812K | 0.1% | 109 |
|
Other funds holding GSK
JEST
Glenview Trust's GSK Position: Q1 2026 in Review
Glenview Trust held its GSK (GSK) position steady in Q1 2026 at 7,582 shares worth $418K. The position accounts for 0.01% of the portfolio, ranked #385.
Glenview Trust first reported a position in GSK in Q4 2013 and has held it in 41 quarters since. The position peaked at $1.2M in Q2 2017. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Glenview Trust held 7,582 shares of GSK worth $418K as of Q1 2026.
- Glenview Trust left its GSK share count unchanged in Q1 2026.
- GSK made up 0.01% of Glenview Trust's portfolio in Q1 2026, its #385 holding.
- Glenview Trust first reported a position in GSK in Q4 2013 and has held it in 41 quarters since.
- Glenview Trust's GSK position peaked at $1.2M in Q2 2017.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.